AzTrials
AzTrials

TracheostomyDECATRACNCT03512054

Pilot Study Evaluating the Success (= Safe Decannulation) of a Standardized Tracheotomy Weaning Procedure in Brain-injury's Patients

A study testing Standardized 5-step weaning procedure in people with Tracheostomy and Brain Injuries, run by University Hospital, Bordeaux at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Tracheotomy weaning and decannulation are one of the important problems in the neurosurgical care unit. Aside from medical, psychological, sociological, economical and ethics problems, tracheotomy increases the duration of the hospital stay and conditions the secondarily future medical care (better re-education after… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Tracheostomy, Brain Injuries
What is being tested?
Standardized 5-step weaning procedure
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
20 Jun 2018to 18 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age at least 18 years old
  • brain-injury disease
  • tracheotomy act while in neurosurgery or reanimation stay
  • no artificial ventilation
  • medical cover
  • free, informed and express consent by the patient or his legal representative (no later than the day after the inclusion and before all exam necessary for the research)

Who cannot join

  • Malnutrition (defines by the age) :
  • age < 70 years old: body mass index (B.D.I.) <16 kg/m² or albuminemia <20 g/L
  • age > 70 years old: body mass index (B.D.I.) <18 kg/m² or albuminemia <30 g/L

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Bordeaux

    Bordeaux, 33000

Other trials in France

About this study

Tracheotomy weaning and decannulation are one of the important problems in the neurosurgical care unit. Aside from medical, psychological, sociological, economical and ethics problems, tracheotomy increases the duration of the hospital stay and conditions the secondarily future medical care (better re-education after the injury).

However, according to investigators practices, that patients who were decannulated with success can go into a secondary care residence more easily.

This research will demonstrate that all patients included can be decannulated without risk of a new recannulation in the 96 hours.

Read the detailed description

Brain injury patients with alertness disorders, wake-up delay and / or swallowing disorders, frequently have a tracheotomy. This tracheotomy is often a problem when it comes to find a bed in a secondary care unit, which is better adapted to the patient rehabilitation. Unfortunately, there is little room to accept this type of patient. It is therefore appropriate to do the weaning during the neurosurgery unit stay.

Bibliographical studies indicate few recommendations as to weaning outside intensive care units. In the neurosurgery units at the University Hospital of Bordeaux, during 3 years (2014-2016), investigators have practiced 29 decannulations without recannulation, over 37 brain injury patients, with a multi-professional team (neurosurgeon, physiotherapist, nurse, caregiver…) to produce a weaning process.

From where investigators hypothesis: using a multi-professional weaning process, checking the patient's stability during the different weaning steps, can lead to decide to decannulate or not without any risk.

Being tested
Standardized 5-step weaning procedure
Keywords
Tracheostomy, Decannulation, Rehabilitation, Brain injury, Neurosurgery
Medical subject headings
Brain Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standardized 5-step weaning procedureProcedure or surgery

    Weaning process in 5 steps (0-4), by a multi-professional team (neurosurgeon, physiotherapist, nurse, caregiver…) Stability criteria are defined for each person, after validation pass the next step. Stability criteria degradation return to the previous step. Weaning process can take back after stability criteria renormalization.

    Step 0: cuff deflate. Step 1: occlusion test. Steps 0 and 1 can assess the freedom and protect capacity airway. In failure process, we can propose a nasofibroscopy.

    Step 2: Phonatory Valve. Respiratory rehabilitation/ swallowing, limiting breathing effort. The valve ought to stay 12 hours before going to the step 3.

    Step 3: Plug. Finish the Respiratory rehabilitation/ swallowing. The plug ought to stay 24hours minimum before going to the step 4.

    Step 4: Decannulation

Study groups in NCT03512054
Study groupRoleWhat they receive
Experimental procedureExperimentalNot described
Receives: Procedure: Standardized 5-step weaning procedure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of safe decannulation

    The main objective is to determine the effectiveness of the standardized 5-step weaning procedure for selecting patients to be decannulated without failure. This is measured by the proportion of safe decannulation for all decannulated tracheotomised patients included in the study. The failure of decannulation is defined by a recannulation within 96h.

    Measured: Up to 3 month after weaning procedure start (Inclusion)

Secondary outcomes (5)
  1. Reasons of failure in weaning process

    Measured: Up to 3 month after weaning procedure start (Inclusion)

  2. Life threatening event occurrence during the weaning procedure

    Life threatening event is defined by one of the following:

    • cardiorespiratory failure,
    • septic shock,
    • cardiorespiratory arrest,
    • acute respiratory failure,
    • acute neurological condition or severe electrolyte disturbances

    Measured: Up to 3 month after weaning procedure start (Inclusion)

  3. Mortality at 6 months

    Measured: 6 month after weaning procedure start (Inclusion)

  4. Communication capacity with CRS-R (Coma Recovery Scale Revised) communication subscore

    Communication subscore:

    • 2 Functional Accurate
    • 1 Non-Functional: Intentional
    • 0 None

    Measured: Up 6 month after weaning procedure start (Inclusion)

  5. Nutrition evolution with DOSS (Dysphagia Outcome and Severity Scale) score

    7 points scale:

    • Level 1: Severe dysphagia: Unable to tolerate any Per Oral safely
    • Level 7: Normal in all situations

    Measured: Up 6 month after weaning procedure start (Inclusion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2018
  2. Study start20 Jun 2018
  3. Primary completion24 Dec 2019
  4. Study completion18 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03512054
Sponsor's protocol ID
CHUBX 2017/31
Other IDs
2017-A03316-47
Acronym
DECATRAC
Status last verified
Dec 2020
First submitted
23 Mar 2018
Last updated
14 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gallice T, Cugy E, Germain C, Barthelemy C, Laimay J, Gaube J, Engelhardt M, Branchard O, Maloizel E, Frison E, Dehail P, Cuny E. A Pluridisciplinary Tracheostomy Weaning Protocol for Brain-Injured Patients, Outside of the Intensive Care Unit and Without Instrumental Assessment: Results of Pilot Study. Dysphagia. 2024 Aug;39(4):608-622. doi: 10.1007/s00455-023-10641-7. Epub 2023 Dec 7.

    PubMed 38062168

Questions about this trial

What is this clinical trial studying?

A study testing Standardized 5-step weaning procedure in people with Tracheostomy and Brain Injuries, run by University Hospital, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of safe decannulation (time frame: Up to 3 month after weaning procedure start (Inclusion)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03512054, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in